Peter Smitham

Dr. Peter Smitham

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2012 in The Open Orthopaedics Journal
Verified
Journal Article
Open access
III Ibrahim
I Ibrahim
WKW.S Khan
W.S Khan
NGN Goddard
N Goddard
PSPeter Smitham
Peter Smitham
Carpal Tunnel Syndrome (CTS) remains a puzzling and disabling condition present in 3.8% of the general population. CTS is the most well-known and frequent form of median nerve entrapment, and accounts for 90% of all entrapment neuropathies. This review aims to provide an overview of this common condition, with an emphasis on the pathophysiology involved in CTS. The clinical presentation and risk factors associated with CTS are discussed in this paper. Also, the various methods of diagnosis are explored; including nerve conduction studies, ultrasound, and magnetic resonance imaging.

29 August 2017 in International Journal of Technology Assessment in Health Care
Verified
Journal Article
Open access
PDF file
DHDeborah Hill
Deborah Hill
Catherine HollowayCatherine Holloway
Catherine Holloway
DRDafne Zuleima Morgado Ramirez
Dafne Zuleima Morgado Ramirez
PSPeter Smitham
Peter Smitham
YPYannis Pappas
Yannis Pappas
Objectives: Exoskeletons are electromechanical devices that are worn by a human operator to increase their physical performance. Several exoskeletons have been developed to restore functional movements, such as walking, for those with paralysis due to neurological impairment. However, existing exoskeletons have limitations with respect to affordability, size, weight, speed, and efficiency, which may reduce their functional application. Therefore, the aim of this scoping review is to collect and narratively synthesize the perspectives of users of exoskeleton technology.Methods: A systematic literature search was conducted across several healthcare related online databases.Results: A total of 4,619 articles were identified, of which 51 were selected for full review. Only three studies were identified that met the inclusion criteria. Of these, one showed an incongruence between users’ expectations and experiences of device use; another reported perspectives on potential rather than actual device use, ranking design features in order of perceived importance; and the other reported ratings of ease of device use in training.Conclusions: The heterogeneity of studies included within this review, leave the authors unable to suggest consensus as to user perspectives of exoskeleton technology. However, it is apparent that users are able to suggest priorities for exoskeleton design and that users’ perspectives of exoskeleton technology might change in response to experience of use. The authors, therefore, suggest that exoskeleton design should be an iterative process, whereby user perspectives are sought, incorporated and refined by tangible experience, to ensure that devices developed are acceptable to and usable by the populations they seek to re-enable.

4 May 2013 in Osteoporosis International
Verified
Journal Article
Open access
PDF file
JJJ. Jeyabalan
J. Jeyabalan
Benoit ViolletBenoit Viollet
Benoit Viollet
PSPeter Smitham
Peter Smitham
SES. A. Ellis
S. A. Ellis
GZG. Zaman
G. Zaman
CCC. Chenu
C. Chenu
Summary The present study shows no adverse effects of the anti-diabetic drug metformin on bone mass and fracture healing in rodents but demonstrates that metformin is not osteogenic in vivo, as previously proposed. Introduction In view of the increased incidence of fractures in patients with type 2 diabetes mellitus (T2DM), we investigated the effects of metformin, a widely used T2DM therapy, on bone mass and fracture healing in vivo using two different rodent models and modes of metformin administration. Methods We first subjected 12-week-old female C57BL/6 mice to ovariectomy (OVX). Four weeks after OVX, mice received either saline or metformin administered by gavage (100 mg/kg/daily). After 4 weeks of treatment, bone micro-architecture and cellular activity were determined in tibia by micro-CT and bone histomorphometry. In another experiment, female Wistar rats aged 3 months were given only water or metformin for 8 weeks via the drinking water (2 mg/ml). After 4 weeks of treatment, a mid-diaphyseal osteotomy was performed in the left femur. Rats were sacrificed 4 weeks after osteotomy and bone architecture analysed by micro-CT in the right tibia while fracture healing and callus volume were determined in the left femur by X-ray analysis and micro-CT, respectively. Results In both models, our results show no significant differences in cortical and trabecular bone architecture in metformin-treated rodents compared to saline. Metformin had no effect on bone resorption but reduced bone formation rate in trabecular bone. Mean X-ray scores assessed on control and metformin fractures showed no significant differences of healing between the groups. Fracture callus volume and mineral content after 4 weeks were similar in both groups. Conclusions Our results indicate that metformin has no effect on bone mass in vivo or fracture healing in rodents.

1 July 2019 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
PSPeter Smitham
Peter Smitham
TCTania A. Carbone
Tania A. Carbone
SBScott M. Bolam
Scott M. Bolam
YKYoung S. Kim
Young S. Kim
Stuart Adam CallaryStuart Adam Callary
Stuart Adam Callary
Lucian Bogdan SolomonLucian Bogdan Solomon
Lucian Bogdan Solomon

18 April 2016 in BMJ Open
Verified
Journal Article
Open access
PDF file
RHRhiannon L Harries
Rhiannon L Harries
VGVimal J Gokani
Vimal J Gokani
PSPeter Smitham
Peter Smitham
JFJ Edward F Fitzgerald
J Edward F Fitzgerald
Objectives Generational changes in lifestyle expectations, working environments and the feminisation of the medical workforce have seen an increased demand in postgraduate less than full-time training (LTFT). Despite this, concerns remain regarding access to, and information about, flexible training for surgeons. This study aimed to assess the opinions and experiences of LTFT for surgical trainees. Design Prospective, questionnaire-based cross-sectional study. Setting/participants An electronic, self-administered questionnaire was distributed in the UK and Republic of Ireland through mailing lists via the Association of Surgeons in Training and British Orthopedic Trainee Association. Results Overall, 876 completed responses were received, representing all grades of trainee across all 10 surgical specialties. Median age was 33 years and 63.4% were female. Of those who had undertaken LTFT, 92.5% (148/160) were female. Most worked 60% of a full-time post (86/160, 53.8%). The reasons for either choosing or considering LTFT were childrearing (82.7%), caring for a dependent (12.6%) and sporting commitments (6.8%). Males were less likely to list childrearing than females (64.9% vs 87.6%; p<0.0001). Only 38% (60/160) found the application process easy and 53.8% (86/160) experienced undermining behaviour from workplace staff as a result of undertaking LTFT. Of all respondents, an additional 53.7% (385/716) would consider LTFT in future; 27.5% of which were male (106/385). Overall, only 9.9% of all respondents rated current LTFT information as adequate. Common sources of information were other trainees (47.3%), educational supervisors (20.6%) and local postgraduate school website (19.5%). Conclusions Over half of surgical trainees working LTFT have experienced undermining behaviour as a result of their LTFT. Despite a reported need for LTFT in both genders, this remains difficult to organise, access to useful information is poor and negative attitudes among staff remain. Recommendations are made to provide improved support and information for those wishing to pursue LTFT.

1 April 2009 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MPMatthew H. Pelletier
Matthew H. Pelletier
LMLawrie Malisano
Lawrie Malisano
PSPeter Smitham
Peter Smitham
KOKoji Okamoto
Koji Okamoto
WWWilliam Walsh
William Walsh